Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use

   
   

The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide of formula 1, which may be used for example for tumor therapy.

 
Web www.patentalert.com

< Triple array defibrillation catheter and method of using the same

< Method for determining the concentration of glucose in a body fluid with glucose-containing perfusate

> Thrombin receptor antagonists

> Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use

~ 00181